Literature DB >> 35272853

Total-body PET/CT - First Clinical Experiences and Future Perspectives.

Quinn Kwan-Tai Ng1, Elizabeth Katherine Anna Triumbari2, Negar Omidvari3, Simon R Cherry4, Ramsey D Badawi4, Lorenzo Nardo5.   

Abstract

Total-body PET has come a long way from its first conception to today, with both total-body and long axial field of view (> 1m) scanners now being commercially available world-wide. The conspicuous signal collection efficiency gain, coupled with high spatial resolution, allows for higher sensitivity and improved lesion detection, enhancing several clinical applications not readily available on current conventional PET/CT scanners. This technology can provide (a) reduction in acquisition times with preservation of diagnostic quality images, benefitting specific clinical situations (i.e. pediatric patients) and the use of several existing radiotracers that present transient uptake over time and where small differences in acquisition time can greatly impact interpretation of images; (b) reduction in administered activity with minimal impact on image noise, thus reducing effective dose to the patient, improving staff safety, and helping with logistical concerns for short-lived radionuclides or long-lived radionuclides with poor dosimetry profiles that have had limited use on conventional PET scanners until now; (c) delayed scanning, that has shown to increase the detection of even small and previously occult malignant lesions by improved clearance in regions of significant background activity and by reduced visibility of coexisting inflammatory processes; (d) improvement in image quality, as a consequence of higher spatial resolution and sensitivity of total-body scanners, implying better appreciation of small structures and clinical implications with downstream prognostic consequences for patients; (e) simultaneous total-body dynamic imaging, that allows the measurement of full spatiotemporal distribution of radiotracers, kinetic modeling, and creation of multiparametric images, providing physiologic and biologically relevant data of the entire body at the same time. On the other hand, the higher physical and clinical sensitivity of total-body scanners bring along some limitations and challenges. The strong impact on clinical sensitivity potentially increases the number of false positive findings if the radiologist does not recalibrate interpretation considering the new technique. Delayed scanning causes logistical issues and introduces new interpretation questions for radiologists. Data storage capacity, longer processing and reconstruction time issues are other limitations, but they may be overcome in the near future by advancements in reconstruction algorithms and computing hardware.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35272853      PMCID: PMC9439875          DOI: 10.1053/j.semnuclmed.2022.01.002

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.802


  30 in total

1.  Relative Patlak plot for dynamic PET parametric imaging without the need for early-time input function.

Authors:  Yang Zuo; Jinyi Qi; Guobao Wang
Journal:  Phys Med Biol       Date:  2018-08-10       Impact factor: 3.609

Review 2.  Clinical Implementation of Total-Body PET/CT at University of California, Davis.

Authors:  Lorenzo Nardo; Yasser G Abdelhafez; Benjamin A Spencer; Ramsey D Badawi
Journal:  PET Clin       Date:  2021-01

3.  Efficient Delay Correction for Total-Body PET Kinetic Modeling Using Pulse Timing Methods.

Authors:  Elizabeth J Li; Benjamin A Spencer; Jeffrey P Schmall; Yasser Abdelhafez; Ramsey D Badawi; Guobao Wang; Simon R Cherry
Journal:  J Nucl Med       Date:  2021-12-21       Impact factor: 11.082

4.  Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling.

Authors:  Guobao Wang; Lorenzo Nardo; Mamta Parikh; Yasser G Abdelhafez; Elizabeth Li; Benjamin A Spencer; Jinyi Qi; Terry Jones; Simon R Cherry; Ramsey D Badawi
Journal:  J Nucl Med       Date:  2021-11-18       Impact factor: 11.082

5.  Total-Body Quantitative Parametric Imaging of Early Kinetics of 18F-FDG.

Authors:  Tao Feng; Yizhang Zhao; Hongcheng Shi; Hongdi Li; Xuezhu Zhang; Guobao Wang; Patricia M Price; Ramsey D Badawi; Simon R Cherry; Terry Jones
Journal:  J Nucl Med       Date:  2020-09-18       Impact factor: 10.057

Review 6.  Total-Body PET Imaging in Infectious Diseases.

Authors:  Timothy J Henrich; Terry Jones; Denis Beckford-Vera; Patricia M Price; Henry F VanBrocklin
Journal:  PET Clin       Date:  2020-11-05

Review 7.  Current Perspectives on 89Zr-PET Imaging.

Authors:  Joon-Kee Yoon; Bok-Nam Park; Eun-Kyoung Ryu; Young-Sil An; Su-Jin Lee
Journal:  Int J Mol Sci       Date:  2020-06-17       Impact factor: 5.923

8.  PennPET Explorer: Human Imaging on a Whole-Body Imager.

Authors:  Austin R Pantel; Varsha Viswanath; Margaret E Daube-Witherspoon; Jacob G Dubroff; Gerd Muehllehner; Michael J Parma; Daniel A Pryma; Erin K Schubert; David A Mankoff; Joel S Karp
Journal:  J Nucl Med       Date:  2019-09-27       Impact factor: 11.082

9.  18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.

Authors:  Jeremie Calais; Francesco Ceci; Matthias Eiber; Thomas A Hope; Michael S Hofman; Christoph Rischpler; Tore Bach-Gansmo; Cristina Nanni; Bital Savir-Baruch; David Elashoff; Tristan Grogan; Magnus Dahlbom; Roger Slavik; Jeannine Gartmann; Kathleen Nguyen; Vincent Lok; Hossein Jadvar; Amar U Kishan; Matthew B Rettig; Robert E Reiter; Wolfgang P Fendler; Johannes Czernin
Journal:  Lancet Oncol       Date:  2019-07-30       Impact factor: 41.316

10.  Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT.

Authors:  Ian Alberts; Jan-Niklas Hünermund; George Prenosil; Clemens Mingels; Karl Peter Bohn; Marco Viscione; Hasan Sari; Bernd Vollnberg; Kuangyu Shi; Ali Afshar-Oromieh; Axel Rominger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-02       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.